Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition
Simon J. Hogg, Olga Motorna, Leonie A. Cluse, Timothy M. Johanson, Hannah D. Coughlan, Ramya Raviram, Robert M. Myers, Matteo Costacurta, Izabela Todorovski, Lizzy Pijpers, Stefan Bjelosevic, Tobias Williams, Shannon N. Huskins, Conor J. Kearney, Jennifer R. Devlin, Zheng Fan, Jafar S. Jabbari, Ben P. Martin, Mohamed Fareh, Madison J. Kelly, Daphné Dupéré-Richer, Jarrod J. Sandow, Breon Feran, Deborah A. Knight, Tiffany Khong, Andrew Spencer, Simon J. Harrison, Gareth P. Gregory, Vihandha O. Wickramasinghe, Andrew I. Webb, Phillippa C. Taberlay, Kenneth D. Bromberg, Albert Lai, Anthony T. Papenfuss, Gordon K. Smyth, Rhys S. Allan, Jonathan D. Licht, Dan A. Landau, Omar Abdel‐Wahab, Jake Shortt, Stephin J. Vervoort, Ricky W. Johnstone
Topics & Concepts
AcetylationBiologyChromatinHistoneEpigeneticsEpigenomicsChromatin remodelingCancer researchP300-CBP Transcription FactorsCell biologyComputational biologyGeneticsDNA methylationHistone AcetyltransferasesGene expressionGeneGenomics and Chromatin DynamicsEpigenetics and DNA MethylationProtein Degradation and Inhibitors